Ariel Ganz, PhD

Ariel Ganz is a scientist and investor in precision health. She is founder and managing partner of Arben Ventures, a pre-seed and seed fund for early-stage health and longevity companies, and an affiliate of the Department of Genetics at Stanford University.

She earned a PhD in molecular nutrition at Cornell University, with minors in chemistry and biochemistry, supported by an NIH training grant. Her doctoral research looked at genetic and biochemical differences in how people metabolize nutrients. As a postdoctoral researcher in Michael Snyder's lab at Stanford she applied multi-omics methods to research on mental health and wellbeing.

At Stanford she co-founded the Mental Healthcare Innovations Summit and co-taught a course called Engineering Wellness. She has published more than 20 peer-reviewed papers.